Appellant: Patent Board ‘Misunderstood’ Meaning Of ‘Angioplasty’

WASHINGTON, D.C. — The owner of purportedly “groundbreaking” technology related to the treatment of cardiovascular disease maintains on appeal to the Federal Circuit U.S. Court of Appeals that its patent was...

Already a subscriber? Click here to view full article